x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Adis Journal Podcasts

Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.

science life sciences

All Episodes

19:56

Social Determinants of Health in Metastatic Breast...

Adis Journal Podcasts ·

2025/12/17

This podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-025-00406-7. All conflicts of interest can be found online. This podcast is intended for medical professionals.Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any

en

21:26

Burgeoning Non-Muscle Invasive Bladder Cancer Space:...

Adis Journal Podcasts ·

2025/12/16

In this plain language podcast, the authors discuss highlights from the American Urological Association (AUA) Annual Meeting 2025. These insights come from the perspective of an expert patient and physician, both of whom have experience and expertise in the field of bladder cancer. This podcast is intended to broaden the reach of complex data and insights from AUA 2025 to a broader audience, including non-specialists, helping enable better informed treatment decisions between patients and healthcare

en

31:27

The Role of Comorbidities in Treatment...

Adis Journal Podcasts ·

2025/12/08

Managing prostate cancer today means balancing cancer control with overall health and wellbeing. This episode explores how chronic conditions, frailty, and quality-of-life considerations shape treatment choices from localised to advanced disease. Authors discuss why survival data has shifted the rationale for radical interventions, the complexities introduced by systemic therapy, and why assessing physiological age matters more than chronological age. Discover how comprehensive geriatric assessment

en

33:02

Patient and Physician Perspectives on Prostate Cancer...

Adis Journal Podcasts ·

2025/11/27

In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed. These insights come from the perspective of an expert patient and physician, both of whom have experience and expertise in the field of prostate cancer. This podcast is intended to broaden the reach of complex data and insights from ASCO 2025 to a broader audience, including non-specialists, helping enable better-informed treatment decisions between patients and

en

30:06

Bronchiectasis Treatment Goals, Unmet Needs, and...

Adis Journal Podcasts ·

2025/11/24

This podcast is published open access in Pulmonary Therapy and is fully citeable. You can access the original published podcast article through the Pulmonary Therapy website and by using this link: https://link.springer.com/article/10.1007/s41030-025-00330-1. All conflicts of interest can be found online. This podcast is intended for medical professionals.Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any

en

34:28

Real-World Perspectives on Switching Patients With...

Adis Journal Podcasts ·

2025/11/21

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the XX website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03391-5. All conflicts of interest can be found online. This podcast is intended for medical professionals.Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use,

en

47:10

Treatment in R/M-SCCHN in the Year 2025 - Standard...

Adis Journal Podcasts ·

2025/11/21

A Podcast Discussion on Medical Treatment in R/M-SCCHN in the Year 2025—Standard and Considerations for an Individualized Treatment In this podcast, speakers Dr Konrad Klinghammer and Dr Philipp Ivanyi discuss the general principles of systemic therapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), with a focus on key phase 3 clinical trials such as KEYNOTE-048 and EXTREME. The strengths and limitations of these studies are evaluated, and in the context of

en

31:42

Living with Eosinophilic Granulomatosis with...

Adis Journal Podcasts ·

2025/11/03

Living with Eosinophilic Granulomatosis with Polyangiitis (EGPA): Podcast of a Patient-Physician DiscussionThis podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03400-7. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access: This podcast is

en

29:21

Exploring two new, validated disease specific outcome...

Adis Journal Podcasts ·

2025/10/24

This podcast is published open access in Dermatology and Therapy and is fully citeable. You can access the original published podcast article through the Dermatology and Therapy website and by using this link:https://link.springer.com/article/10.1007/s13555-025-01551-7. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any

en

45:25

Patient and Physician Perspectives on Multiple...

Adis Journal Podcasts ·

2025/10/23

Patient and Physician Perspectives on Multiple Myeloma Data Presented at ASCO and EHA 2025: A Podcast In this plain language podcast, highlights from the American Society of Clinical Oncology (ASCO) Annual Meeting 2025 are discussed, supplemented with additional reflections from the European Hematology Association (EHA) 2025 Congress. These insights come from the perspective of an expert patient and physician, both of whom have experience and expertise in the field of multiple myeloma (MM). This

en

18:46

The Phase 2b COPERNICUS Study of Subcutaneous...

Adis Journal Podcasts ·

2025/10/13

The Phase 2b COPERNICUS Study of Subcutaneous Amivantamab with Lazertinib as First-Line Treatment, or with Chemotherapy as Second-Line Treatment, for EGFR-Mutated Non-Small Cell Lung Cancer: a VodcastDr. Balazs Halmos and Dr. Melissa Johnson present the phase 2b COPERNICUS study evaluating subcutaneous amivantamab, with lazertinib as first-line treatment, or with chemotherapy as second-line treatment for EGFR-mutated non-small cell lung cancer.The intent of this vodcast is to review the study

en

39:22

Podcast Synopsis of Updates to the European Renal...

Adis Journal Podcasts ·

2025/10/02

This podcast is published open access in Advances in Therapy and is fully citeable. You can access the original published podcast article through the Advances in Therapy website and by using this link: https://link.springer.com/article/10.1007/s12325-025-03366-6. All conflicts of interest can be found online. This podcast is intended for medical professionals.Open Access This podcast is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any

en

30:18

Lung Health & RSV: Podcast of a Patient–Physician...

Adis Journal Podcasts ·

2025/09/23

Lung Health and Respiratory Syncytial Virus: Podcast of a Patient–Physician Discussion Based on Insights from a Patient Advisory Board MeetingThis podcast is published open access in Infectious Diseases and Therapy and is fully citeable. You can access the original published podcast article through the Infectious Diseases and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40121-025-01216-0. All conflicts of interest can be found online. This podcast is intended

en

27:24

The Role of Oncology Nurses and Advanced Practice...

Adis Journal Podcasts ·

2025/09/17

The Role of Oncology Nurses and Advanced Practice Providers in the Treatment of Patients With HRR-Deficient mCRPC Receiving Talazoparib Plus Enzalutamide: A PodcastThis podcast is published open access in Oncology and Therapy and is fully citeable. You can access the original published podcast article through the Oncology and Therapy website and by using this link: https://link.springer.com/article/10.1007/s40487-025-00376-w. All conflicts of interest can be found online. This podcast is intended

en

25:38

Managing Drug Interactions with Enzalutamide in...

Adis Journal Podcasts ·

2025/09/17

Managing Drug Interactions with Enzalutamide in Patients with Prostate Cancer This podcast is published open access in Drug Safety and is fully citeable. You can access the original published podcast article through the Drug Safety website and by using this link: https://link.springer.com/article/10.1007/s40264-025-01600-2. All conflicts of interest can be found online. This podcast is intended for medical professionals. Open Access This podcast is licensed under a Creative Commons

en

8:53

From Non-believer to Believer: A Conversation on the...

Adis Journal Podcasts ·

2025/09/15

From Non-believer to Believer: A Podcast Conversation on the Journey from Skeptic to Proponent of Oncology Real-World Evidence In this podcast, the hosts Dr Adam Brufsky and Dr Raymond Liu share their personal experiences with real-world evidence (RWE) and how they have come to be advocates for considering RWE as a supplement to randomized controlled trial (RCT) findings to help guide decision making in the clinic. They discuss the limitations of RCTs in capturing diverse patient populations and

en

12:43

A Practical Approach to Understanding Real-World...

Adis Journal Podcasts ·

2025/09/15

A Practical Approach to Understanding Real-World Study Methodology in Cancer Research: A Vodcast This vodcast intends to be a practical guide for clinicians by clarifying aspects of real-world study methodology. As both practicing oncologists and researchers with extensive real-world data experience, the hosts Dr Adam Brufsky and Dr Winson Cheung discuss types of study designs and real-world data source considerations. An overview of statistical techniques for mitigating treatment-selection bias is

en

10:32

Real-World Studies & Randomized Controlled Trials:...

Adis Journal Podcasts ·

2025/09/15

Real-World Studies and Randomized Controlled Trials: A Podcast Discussion of the Relative Strengths and Limitations of These Complementary Designs for Cancer Research This podcast aims to be a resource for clinicians by exploring the strengths and limitations of randomized controlled trials (RCTs) and real-world studies in the context of cancer research. The hosts Dr Adam Brufsky and Dr Christos Vaklavas, both of whom are practicing oncologists, provide context for the emergence of modern

en

40:32

Treatment Optimization and Management of AEs with...

Adis Journal Podcasts ·

2025/08/20

In this podcast "Treatment Optimization and Management of AEs with Enfortumab Vedotin + Pembrolizumab for Untreated Locally Advanced/Metastatic Urothelial Cancer: A Podcast", authors discuss the management of adverse events (AEs) with enfortumab vedotin + pembrolizumab based on their personal experiences with clinical trials and in their practices and provide perspectives for healthcare professionals on practical management of common AEs and effective dose management strategies. This may help

en

18:46

Clinical Assessment of Alopecia Areata Severity and...

Adis Journal Podcasts ·

2025/08/14

In this podcast, Dr. Zoe Apalla from the Aristotle University of Thessaloniki, Thessaloniki, Greece, and Dr. Katya Harfmann from the Nationwide Children’s Hospital, Columbus, OH, USA discuss tools for assessing alopecia areata severity, including the Severity of Alopecia Tool, AA Scale, and AA Severity and Morbidity Index. An interactive digital feature is provided for this article at the following link: https://datahub.pfizer.com/aaseverity. This podcast is published open access in the American

en

52 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter